posted on 2020-08-17, 19:43authored byArsene F. Hobabagabo, Nana H. Osei-Tutu, Thomas Hormenu, Elyssa M. Shoup, Christopher W. DuBose, Lilian S. Mabundo, Joon Ha, Arthur Sherman, Stephanie T. Chung, David B. Sacks, Anne E. Sumner
<b>Objectives:</b> In African-born blacks living in America, we determined by
BMI category: (a) prevalence of Abnl-GT; (b)
diagnostic value and reproducibility of HbA<sub>1c</sub>, fructosamine and GA.
<p><b>Methods</b>: Participants (n=416, male: 66%; BMI: 27.7±4.5kg/m<sup>2</sup>
(mean±SD)) had OGTT with HbA<sub>1c</sub>, GA, and fructosamine assayed. These
glycemic markers were repeated 11±7d later. Abnl-GT diagnosis required: 0h≥5.6mmol/L
(≥100 mg/dL) and/or 2h≥7.8mmol/L (≥140 mg/dL). Thresholds for HbA<sub>1c</sub>, GA and
fructosamine were the values at the 75<sup>th</sup> percentile for the
population (39 mmol/mol (5.7%), 14.2%, 234µmol/L, respectively). </p>
<p><b>Results</b>: Abnl-GT prevalence in the nonobese and
obese were: 34% vs. 42%, (<i>P</i>=0.124). Reproducibility was excellent for HbA<sub>1c</sub> and
GA (both κ≥0.8), but moderate
for fructosamine (κ=0.6). Focusing
on HbA<sub>1c</sub> and GA in the nonobese, we found as single tests the sensitivities
of HbA<sub>1c</sub> and GA were: 36% vs. 37%, (<i>P</i>=0.529). Combining HbA<sub>1c </sub>and GA, sensitivity
increased to 58% because GA identified 37% of Africans with Abnl-GT not
detected by HbA<sub>1c</sub> (<i>P</i>-value: both tests vs. HbA<sub>1c</sub> alone
<0.001). For the obese,
sensitivities for HbA<sub>1c</sub>, GA and the combined tests were: 60%, 27%,
67%, respectively. Combined test sensitivity did not differ from HbA<sub>1c</sub>
alone (<i>P</i>=0.25) because
GA detected only 10% of obese Africans with Abnl-GT not detected by HbA<sub>1c</sub>.
</p>
<p><b>Conclusion</b>: Adding GA
to HbA<sub>1c</sub> improves detection of Abnl-GT in nonobese Africans.</p>
<br><b></b>
Funding
NIH/NIDDK/NIMHD Intramural Program and the NIH Clinical Center.